COVID-19 Rapid Response: Identifying & developing next-generation COVID-19 therapeutics
$6,325,000.00
Grant Value
2023-24
Fiscal Year
Description
Identify and develop antibody therapeutics for response and preparedness against COVID-19, and expand capacity for rapid development and delivery of antibody therapeutics.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Grant Details
Recipient
AbCellera Biologics Inc.
Operating as: AbCellera
Location
Vancouver, BC V5Y 0A1
Agreement Details
Number: 1002444
Reference: 172-2022-2023-Q4-1002444
Timeline
Start: Nov. 1, 2022
End: March 31, 2024
Program
Industrial Research Assistance Program Contributions to Firms
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or …
Sector
Professional, scientific and technical services (541710)
Your Contribution
Calculate how much you personally contributed to this grant through your taxes.
Calculate My Share